Patients taking weight-loss drugs often make 5 critical mistakes, doctor warns
Key Points:
- GLP-1 drugs like semaglutide and tirzepatide, initially used for diabetes and weight loss, show promising benefits for cardiovascular and kidney health, but experts warn improper use can cause health issues.
- Dr. Meena T. Malhotra highlights improvements in brain, heart, liver, and kidney function among patients using GLP-1s, especially those with severe diabetes, but stresses the importance of combining medication with a healthy lifestyle.
- Patients should undergo medical evaluation and ongoing monitoring to avoid side effects and preserve lean muscle mass, with emphasis on adequate protein intake and strength training during treatment.
- Common mistakes include rushing dose increases and inadequate nutrition, which can lead to side effects like pancreatitis and muscle loss; gradual dosing and balanced diets are recommended for optimal results.
- Managing side effects such as nausea and constipation involves lifestyle adjustments like eating smaller meals, reducing fat intake, and incorporating fiber and liquids, helping patients maintain treatment without weight fluctuations.